Anika Therapeutics Inc.

Anika Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
14.58 M
Public Float
10.11 M
Anika Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.06
Market Cap
$584.76 M
Shares Outstanding
14.21 M
Public Float
13.63 M

Profile

Address
32 Wiggins Avenue
Bedford Massachusetts 01730
United States
Employees -
Website http://www.anikatherapeutics.com
Updated 07/08/2019
Anika Therapeutics, Inc. is global medical technology company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical and veterinary.

Financials

View All

Joseph G. Darling
President, Chief Executive Officer & Director
Cheryl R. Blanchard
Director